|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7105 | |
| C12N 15/117 |
| (11) | Number of the document | 3062798 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14809289.3 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/002931 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/062738 |
| Date | 2015-05-07 |
| (30) | Number | Date | Country code |
| PCT/EP2013/0032 | 2013-11-01 | WO |
| (72) |
SCHLAKE, Thomas, DE
THESS, Andreas, DE
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | MODIFIED RNA WITH DECREASED IMMUNOSTIMULATORY PROPERTIES |
| MODIFIED RNA WITH DECREASED IMMUNOSTIMULATORY PROPERTIES |